Mankind Pharma Ltd. is ready to begin buying and selling in Mumbai on Tuesday after elevating 43.3 billion rupees ($529 million) in one in every of India’s largest preliminary public choices of the yr.

Shareholders of the drug and contraceptive maker bought 40 million shares at 1,080 rupees apiece, the highest of a marketed vary that began from 1,026 rupees. Anchor investors like Canada Pension Plan Investment Board, Government of Singapore and Abu Dhabi Investment Authority collectively subscribed to just about 13 billion rupees value of shares. The firm didn’t promote any new inventory.